Skip to content

Entecavir and Truvada an option for HBV for treatment-experienced HIV/HBV-co-infected patients

Accelerated HBV vaccination schedule an option for HIV patients if CD4 cell count is high

Good outcomes among HIV-positive patients having a liver transplant due to cancer

Nucleoside/nucleotide analogue therapy slows liver disease in HIV/HBV-co-infected patients

Accelerated hepatitis B vaccine schedule boosts completion rates in IDUs

Vaccination programmes reduce hepatitis B prevalence in the US, but racial disparities persist

Management of HIV and hepatitis B or C co-infection in resource-limited settings

Viral hepatitis in low and middle-income settings

FTC has potent anti-HBV effect in HIV/HBV coinfected patients, and rate of resistance low